-
30-06-2018, 09:46 AM
#191
-
26-07-2018, 05:23 PM
#192
-
24-09-2018, 05:12 PM
#193
VHT another big tick for this NZ company
-
05-10-2018, 12:35 AM
#194
VHT at a new high up 15% today.Am staying with this trend!
Screening 3.2% of USA women atp.
https://youtu.be/TWx3hlCi8r0
-
05-10-2018, 06:35 PM
#195
-
12-10-2018, 05:18 PM
#196
VHT complete bounce back today on more good developments
Download Document 145.29KB
New Zealand Breast Screening First to Utilize Volpara AI Software to Improve Mammography Quality
Volpara is in multiple large-scale trials with public screening programs across Europe and APAC of its Enterprise software, including the PROCAS II project with the NationalHealth Service in the UK, one of the world’s largest screening programs. BreastScreen Central is the first such organization in the world to purchase the VolparaEnterprise software to use as a key component of its quality assurance protocols, monitoring breast compression, positioning and other factors to improve the consistency of mammographic imaging and patient experience.
-
30-10-2018, 10:36 AM
#197
VHT Excellent result in whats normally a slow time of year. Reoccurring rev and take-up adoption getting better and better , lots of global growth ahead imo.
Appendix 4C - quarterly
-
30-10-2018, 10:05 PM
#198
OPTHEA: latest edition of Bioshares highlights excellent trial results to date (vision improvements) and potential for patient investors to be "very well rewarded" - see summary in today's HC post
-
30-10-2018, 10:30 PM
#199
Thanks heres the detail to make it interesting
Ticker OPT
Opthea CEO Presentation of Trial Updates at OIS@AAO 2018
-
08-11-2018, 02:22 PM
#200
VHT, new high today on no news ,just plenty of belief that this will be a global local.
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks